New Horizon Health (HKSE:06606) ROCE %: 1.22% (As of Jun. 2023)


HKSE:06606 New Horizon Health Ltd HKSE:06606
35 GF Score
Price HK$14.14
View Full Analysis

What is New Horizon Health ROCE %?

New Horizon Health HKSE:06606 35 ROCE % is 1.22% as of Jun. 2023. GuruFocus rates HKSE:06606 with a GF Score™ of 35/100.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. New Horizon Health's annualized ROCE % for the quarter that ended in Jun. 2023 was 1.22%.

New Horizon Health  (HKSE:06606) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

New Horizon Health ROCE % Related Terms

New Horizon Health ROCE % Historical Data

* Premium members only.

The historical data trend for New Horizon Health's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

New Horizon Health ROCE % Chart

New Horizon Health Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
ROCE %
-741.48 -43.88 -144.35 -219.76 -3.07

New Horizon Health Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
ROCE % Get a 7-Day Free Trial Premium Member Only -375.68 -16.71 -5.65 -0.92 1.22
HKSE:06606
35GF Score
New Horizon Health Ltd HKSE:06606
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

New Horizon Health ROCE % Calculation

New Horizon Health's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2022 )  (A: Dec. 2021 )(A: Dec. 2022 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2022 )  (A: Dec. 2021 )(A: Dec. 2022 )
=-80.735/( ( (2882.235 - 236.761) + (2875.346 - 253.978) )/ 2 )
=-80.735/( (2645.474+2621.368)/ 2 )
=-80.735/2633.421
=-3.07 %

New Horizon Health's ROCE % of for the quarter that ended in Jun. 2023 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jun. 2023 )  (Q: Dec. 2022 )(Q: Jun. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jun. 2023 )  (Q: Dec. 2022 )(Q: Jun. 2023 )
=38.614/( ( (2875.346 - 253.978) + (4020.199 - 290.381) )/ 2 )
=38.614/( ( 2621.368 + 3729.818 )/ 2 )
=38.614/3175.593
=1.22 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 1.22% mean?
New Horizon Health (HKSE:06606) has a ROCE % of 1.22% as of Jun. 2023.
Is New Horizon Health's ROCE % too high?
New Horizon Health's current ROCE % is 1.22%. The Medical Devices & Instruments industry median ROCE % is 2.20. New Horizon Health's value of 1.22% is 44.5% below this industry median. Overall, New Horizon Health has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does New Horizon Health's ROCE % compare to ABT and SYK?
New Horizon Health's ROCE % of 1.22% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.20. New Horizon Health's value of 1.22% is 44.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.20, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. New Horizon Health's current ROCE % of 1.22% is 44.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. New Horizon Health's current ROCE % is 1.22%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is New Horizon Health stock overvalued right now?
New Horizon Health (HKSE:06606) has a current ROCE % of 1.22%. The current ROCE % is 1.22% and 44.5% below the Medical Devices & Instruments industry median of 2.20. New Horizon Health's overall GF Score™ is 35/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For New Horizon Health (HKSE:06606), the current ROCE % is 1.22% as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

New Horizon Health Business Description

Address 400 Jiang’er Road, 13th Floor, T1 Building, Binjiang District, Zhejiang, Hangzhou, CHN, 310052
New Horizon Health Ltd is engaged in early cancer screening and in-home testing in China. The company has an early detection and cancer screening-focused pipeline of five products and product candidates with an emphasis on colorectal cancer screening. The company focuses on cancer prevention and cure through screening and early detection. It generates maximum revenue from ColoClear and Pupu Tube products.
35GF Score

Get the complete analysis for HKSE:06606

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$14.14
Price